Share-Based Payments (Tables)

3 Months Ended

Mar. 31, 2020

Share-based Payment Arrangement, Noncash Expense [Abstract]

Summary of restricted common stock vesting dates

The following is a summary of restricted common stock vesting dates as of March 31, 2020 and December 31, 2019, including shares whose issuance has been deferred under the Director Deferred Fee Plan: 

	March 31, 2020	December 31, 2019
Vesting Date	Shares Vesting	Shares Vesting
March 2020	—	36,000
June 2020	31,480	30,592
March 2021	36,000	36,000
March 2022	36,000	36,000
	103,480	138,592

Schedule of restricted stock activity

The following table presents information with respect to the Company’s restricted stock for the three months ended March 31, 2020, including shares whose issuance has been deferred under the Director Deferred Fee Plan:

	March 31, 2020			March 31, 2019
	Shares of  Restricted Stock	Weighted Average  Grant Date Fair  Value (1)		Shares of  Restricted Stock	Weighted Average  Grant Date Fair  Value (1)
Outstanding at beginning of period	894,289	$	15.76	753,973	$	16.77
Granted (2)	888	10.67		108,888	10.50
Cancelled/forfeited	—	—		—	—
Outstanding at end of period	895,177	15.75		862,861	15.98
Unvested at end of period	103,480	$	10.29	136,364	$	10.56

(1)The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date.

(2)Includes 888 and 888 shares of restricted stock attributed to dividends on restricted stock under the Director Deferred Fee Plan for the three months ended March 31, 2020 and March 31, 2019, respectively.